Clinical Trials
-
The five principles for good clinical trials
An abundance of tools is widely available to researchers today that can empower clinical trials to be more adaptive, connected, efficient, flexible, resilient and transparent. The use of new tools in clinical trials can help bridge the gap between research in higher- and lower-income countries. But their potential can be wasted when used without thinking...
-
A new regulation to unify the European research space
The new European Clinical Trials Regulation, which came into application on 31 January 2022, has rung in a new era for clinical trials in the EU. Over the next three years, the new regulation is going to unify the EU into one research space where the same rules and processes for the submission, evaluation and...
-
Ensuring clinical research is at the heart of care
The recent Health and Care Act will help drive a more research active NHS to deliver better healthcare for our communities. It is well established that clinical research activity in the NHS delivers clear benefits to all involved. This includes improved outcomes, lower mortality rates and increased confidence for patients in care being delivered. The...
-
Harnessing the full potential of decentralised clinical trials
Studies that are intentionally planned as decentralised clinical trials provide the best opportunity to optimise the patient-centred capabilities of decentralisation. You would not buy a sportscar and just use it for the two-mile drive to the shops. Instead, you would take it on the open road to take full advantage of its capabilities. The powerful...
-
Public involvement in research leads to a better experience for all
Clinical research shouldn’t just be shaped by the researchers conducting it – the voices of patients, carers and other members of the public are vital. A variety of voices involved in clinical research makes the clinical trial experience a better one for all, with richer results, drawing on patients’ experience and knowledge of what is...
-
How we’re working to achieve equality, diversity and inclusion in clinical trials
The pandemic has brought into sharp focus the health inequalities that currently exist in the UK, with some communities affected significantly worse by COVID-19. The pharmaceutical industry is well placed to play a key role in helping to tackle the issue of health inequalities. A key mechanism for doing this is ensuring that the evidence...
-
How do we improve clinical trials post-pandemic?
Clinical trials during a pandemic have shown that a “quality by design” mindset can future-proof and better clinical research. The COVID-19 pandemic has taught us a lot and yet we can still keep learning. While the pandemic has impacted everyone globally in ways that could never have been imagined, it has provided a spark for...
-
s Sponsored
How digital devices are changing the clinical trial landscape
Changes to the digital trial space are being driven by technological advances that present an increased role for patients. New technologies and devices are enabling a shift from traditional clinical trial formats to decentralised studies with patients and their experience at the core of research. In tandem with this, a new generation of digital-friendly physicians...
-
s Sponsored
Designing technology with patients is helping to improve clinical trials
Patients are playing a central role in the changing approach to clinical trials. Closer involvement of patients in clinical trials is showing significant benefits in improving research. Technology that positively supports patients and sites can make the experience more enjoyable, leading to better data. Bruce Hellman, who runs uMotif – a patient-centric data capture platform...
-
How data has helped to transform clinical trials during the COVID-19 pandemic
A new initiative is helping to find new and effective treatments during the COVID-19 pandemic and increase participation in clinical trials. Data has been shown to have a significant impact on clinical trial research. However, more support is needed at key points where collected patient data can make a real difference – to support feasibility...
Global Cause